Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Alzheimer's Disease

Trial Information

A Biospecimen and Clinical Data Study on Patients With Alzheimer's, Multiple Sclerosis, Parkinson's, and Huntington's, for Drug & Biomarker Discovery

Official Title: A Multi-Center Longitudinal Biorepository Study to Provide Biospecimens & Clinical Data From Neurological Disease Patients To Approved Pre-Clinical And Clinical Investigators for Drug & Biomarker Studies

Summary

The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies. Through such studies, they hope to find new ways to detect, treat, and maybe even prevent or cure health problems.

Phase: N/A

Sponsor: Sanguine Biosciences

Overall Contacts:

Sascha Hasan, PhD, MBA
310.403.5669

Carlyn Crisostomo
Phone: 1.866.619.1301

Locations (1)

Country State City Zip Facility and Contact
United States California Valencia 91355 Sanguine Biosciences
Sascha Hasan, PhD, MBA
310-403-5669
sascha@sanguinebio.com

Sascha Hasan, PhD, MBA
Principal Investigator

Carlyn Crisostomo
Sub-Investigator

NCT ID:NCT01592552

Date Last Changed: May 8, 2012